{"version":"1.2.0","chapters":[{"startTime":0,"endTime":59,"title":"Trailer"},{"startTime":59,"endTime":89,"title":"Introduction"},{"startTime":89,"endTime":256,"title":"From physics to biology to AI"},{"startTime":256,"endTime":445,"title":"Starting FutureHouse as a nonprofit in 2022"},{"startTime":445,"endTime":739,"title":"The role of nonprofits in technology"},{"startTime":739,"endTime":929,"title":"Robin: the first multi-agent scientific discovery system"},{"startTime":929,"endTime":1124,"title":"Where AI is strong and weak in science"},{"startTime":1124,"endTime":1392,"title":"High-throughput reasoning and parasite proteins"},{"startTime":1392,"endTime":1557,"title":"Hypothesis generation vs operational work"},{"startTime":1557,"endTime":1757,"title":"How AI is changing drug discovery"},{"startTime":1757,"endTime":1906,"title":"The bottleneck of human clinical trials"},{"startTime":1906,"endTime":2177,"title":"Peptides and upstarts advantage"},{"startTime":2177,"endTime":2778,"title":"Fixing the clinical trial process"},{"startTime":2778,"endTime":3138,"title":"Using AI to synthesize medical research"},{"startTime":3138,"endTime":4095,"title":"How frontier models differ for specialized tasks"},{"startTime":4095,"endTime":4213,"title":"Will AI ever replace Nobel laureates"},{"startTime":4213,"endTime":4396,"title":"Raising $70 million from pharma investors"},{"startTime":4396,"endTime":4488.417,"title":"Is this time different for AI in drug discovery"}]}